Beam Therapeutics, Inc. (BEAM)

30.23 -2.06 (-6.38%) USD  |  NASDAQ  |  Feb 25, 14:43
More

Beam Therapeutics Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for BEAM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Intellia Therapeutics, Inc. Upgrade
Twist Bioscience Corp. Upgrade
Pacific Biosciences of California, Inc. Upgrade
Stryker Corp. Upgrade
Zimmer Biomet Holdings, Inc. Upgrade